New Treatment Paradigms in Metastatic Breast Cancer
by Chau T. Dang, MD Clifford A. Hudis, MD
Publisher: CMPMedica
Number Of Pages: 137
Publication Date: 2008
ISBN-10 / ASIN: 9781891483615
Binding: Paperback
Despite significant clinical and laboratory progress, breast cancer remains
a major public health problem for women. Each year in the United States alone there are nearly 200,000 cases diagnosed and approximately 40,000 deaths. Since 1990, there has been a steady decline in mortality, attributed to both earlier detection and improved adjuvant treatments. In addition, since 2003 there has also been a decrease in incidence associated
with a reduction in the use of hormone replacement therapies. The key issue and focus of this book, however, is that metastatic breast cancer (MBC), while very treatable in most cases, is not curable.
In this book we have condensed in five chapters a wealth of practical information on the treatment of MBC. Our aim is that these chapters would provide a timely review of the most up-to-date information on chemotherapy, hormonal therapy, anti-angiogenic therapy, anti-HER2 therapy, and supportive care. Treatment for MBC is a rapidly evolving area, especially now that we have entered the era of targeted therapies, and we hope that patients outcomes will continue to improve as newer drugs enter our clinics. We also hope that this book will provide practical and useful information to all clinical oncologists and other health care professionals who treat patients afflicted with this disease.
http://www.book4doc.com/75597
by Chau T. Dang, MD Clifford A. Hudis, MD
Publisher: CMPMedica
Number Of Pages: 137
Publication Date: 2008
ISBN-10 / ASIN: 9781891483615
Binding: Paperback
Despite significant clinical and laboratory progress, breast cancer remains
a major public health problem for women. Each year in the United States alone there are nearly 200,000 cases diagnosed and approximately 40,000 deaths. Since 1990, there has been a steady decline in mortality, attributed to both earlier detection and improved adjuvant treatments. In addition, since 2003 there has also been a decrease in incidence associated
with a reduction in the use of hormone replacement therapies. The key issue and focus of this book, however, is that metastatic breast cancer (MBC), while very treatable in most cases, is not curable.
In this book we have condensed in five chapters a wealth of practical information on the treatment of MBC. Our aim is that these chapters would provide a timely review of the most up-to-date information on chemotherapy, hormonal therapy, anti-angiogenic therapy, anti-HER2 therapy, and supportive care. Treatment for MBC is a rapidly evolving area, especially now that we have entered the era of targeted therapies, and we hope that patients outcomes will continue to improve as newer drugs enter our clinics. We also hope that this book will provide practical and useful information to all clinical oncologists and other health care professionals who treat patients afflicted with this disease.
http://www.book4doc.com/75597
No comments:
Post a Comment